BioSpace News Archive

Press Releases

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

May 23, 2025
·
31 min read
Press Releases

Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

May 23, 2025
·
10 min read
Press Releases

Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

May 23, 2025
·
8 min read
Press Releases

ImPact Biotech Announces Late-Breaking Podium Presentation at ASCO 2025 Highlighting ENLIGHTED Study Interim Analysis

May 23, 2025
·
3 min read
Press Releases

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

May 23, 2025
·
15 min read
Press Releases

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

May 23, 2025
·
8 min read
Press Releases

Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2025
·
22 min read
Press Releases

Servier Presentations at ASCO 2025 Reinforce Company Leadership in IDH-Mutated Cancers

May 23, 2025
·
2 min read
Press Releases

Accent Therapeutics Announces Trial in Progress Poster for First-in-Human Study of ATX-559 at 2025 ASCO Annual Meeting

May 23, 2025
·
4 min read
Press Releases

Volastra Announces Initial Data from First-in-Human Phase I/II Trial of Novel KIF18A Inhibitor VLS-1488 to be Presented at 2025 ASCO Annual Meeting

May 23, 2025
·
4 min read